Mr. Land is the founder and CEO of Irvine Labs, Inc. a DEA Schedule 1 bulk manufacturer of marijuana and psychedelics as well as import and export. Shaun has been working with individual hospitals and up to Fortune 5 health care companies in regulatory, operations and M&A since 1997. He was also previously the co-founder and primary investor in Orgrotech, the State of Oregon’s largest recreational marijuana licensee. Shaun and his team of world-renowned clinical leaders have been focused on large-market, botanical drug development for prescription markets and improving existing, prescription drugs for over 12 years. Irvine Labs has been privately funded by Shaun and has a pipeline of prescription human drugs (Phase 2) and prescription animal drugs (in Pivotal phase). Irvine Labs multiple joint ventures in drug development, manufacturing, and global supply chain for Schedule 1+, Shaun is also entertaining various funding & investment options for the company.